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Molecular Characterization of EmABP, an Apolipoprotein A-I
Binding Protein Secreted by the Echinococcus multilocularis
Metacestode
Abstract
Cestodes are unable to synthesize de novo most of their own membrane lipids, including cholesterol,
and have to take them up from the host during an infection. The underlying molecular mechanisms are
so far unknown. Here we report the identification and characterization of a novel gene, Emabp, which is
expressed by larval stages and adults of the fox-tapeworm Echinococcus multilocularis. The encoded
protein, EmABP, displays significant homologies to apolipoprotein A-I - binding protein (AI-BP) of
mammalian origin and to metazoan YjeF_N domain proteins. Like mammalian AI-BP, EmABP carries
an export-directing signal sequence which is absent in predicted AI-BP orthologs from the related
flatworms Schistosoma japonicum and Schmidtea mediterranea. Using a specific antibody and
immuno-precipitation techniques, we demonstrate that EmABP is secreted into the extra-parasitic
environment and into hydatid fluid of in vitro cultivated metacestode vesicles. Furthermore, we show
that apolipoprotein A-I (apoA-I), a major constituent of cholesterol-transporting high density
lipoproteins, is present in hydatid fluid. By pull-down experiments, we demonstrate that recombinantly
expressed, purified EmABP interacts with purified human apoA-I and is able to precipitate apoA-I from
human serum. Based on these features, and on the suggested function of AI-BP in cholesterol transport
in higher eukaryotes, we propose a role of EmABP in cholesterol- and lipid-uptake mechanisms of
larval E. multilocularis.
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Cestodes are unable to synthesize de novo most of their own membrane lipids, including cholesterol, and
have to take them up from the host during an infection. The underlying molecular mechanisms are so far
unknown. Here we report the identification and characterization of a novel gene, Emabp, which is expressed by
larval stages and adults of the fox tapeworm Echinococcus multilocularis. The encoded protein, EmABP, displays
significant homologies to apolipoprotein A-I binding protein (AI-BP) of mammalian origin and to metazoan
YjeF_N domain proteins. Like mammalian AI-BP, EmABP carries an export-directing signal sequence which
is absent in predicted AI-BP orthologs from the related flatworms Schistosoma japonicum and Schmidtea
mediterranea. Using a specific antibody and immunoprecipitation techniques, we demonstrate that EmABP is
secreted into the extraparasitic environment and into the hydatid fluid of in vitro-cultivated metacestode
vesicles. Furthermore, we show that apolipoprotein A-I (apoA-I), a major constituent of cholesterol-transport-
ing high-density lipoproteins, is present in hydatid fluid. By pulldown experiments, we demonstrate that
recombinantly expressed, purified EmABP interacts with purified human apoA-I and is able to precipitate
apoA-I from human serum. On the basis of these features and the suggested function of AI-BP in cholesterol
transport in higher eukaryotes, we propose a role for EmABP in cholesterol and lipid uptake mechanisms of
larval E. multilocularis.
The metacestode larval stage of the fox tapeworm Echino-
coccus multilocularis is the causative agent of alveolar echino-
coccosis (AE) in humans, one of the most serious and life-
threatening parasitoses of the Northern Hemisphere (16). The
E. multilocularis life cycle involves an adult stage which dwells
in the intestines of definitive hosts, such as foxes or dogs, and
produces infective eggs that contain the parasite’s oncosphere
larva. Upon oral ingestion of the eggs by intermediate hosts
(rodents and, occasionally, humans), the oncosphere is acti-
vated, hatches, and penetrates the intestinal barrier. Within
the liver of the intermediate host, the oncosphere undergoes a
metamorphosis toward the bladder-like metacestode stage
which grows infiltratively, like a malignant tumor, into the
surrounding host tissue. At a later stage of the infection, nu-
merous protoscoleces are formed from the parasite’s germinal
tissue, which are passed onto the definitive host when it takes
the prey (6–8, 16, 49). Human E. multilocularis infections are
relatively rare but pose serious problems to surgical and/or
chemotherapeutic treatment (28). A very similar life cycle is
displayed by the closely related dog tapeworm Echinococcus
granulosus, the causative agent of cystic echinococcosis (CE),
with several modifications concerning the spectrum of host
species (domestic animals), metacestode morphology (uniloc-
ular versus multilocular), and organ tropism (the lung, kidney,
and brain in addition to the liver) (6, 16).
Although E. multilocularis and E. granulosus contain com-
plex mixtures of lipids, including cholesterol, in their mem-
branes, they are unable to synthesize most of these molecules
de novo and share this trait with other cestodes (35). As a
consequence, they have to take up host-derived lipids during
an infection. Particularly in the case of cholesterol, Frayha (19,
20) already demonstrated that this compound cannot be syn-
thesized by both E. multilocularis and E. granulosus and that at
least E. granulosus incorporates radioactively labeled, host-
derived cholesterol during experimental infection of mice. Al-
though several Echinococcus proteins with fatty acid and hy-
drophobic ligand binding properties have been reported (12,
25), none of these displayed cholesterol binding activities nor
has, as yet, any cestode molecule been identified that interacts
with components of the host’s cholesterol transport machinery.
Mammalian cells acquire exogenous cholesterol mainly from
low-density lipoprotein (LDL) particles via the LDL receptor
pathway. During this process, the LDL receptor specifically
interacts with the major protein component of LDL particles,
apolipoprotein B-100 (apoB-100), resulting in the formation of
clathrin-coated vesicles which are processed via the classical
endocytic pathway. Upon fusion of the vesicles with lysosomes,
the entire LDL particle is disassembled by enzymatic hydroly-
sis, releasing cholesterol and lipids for cellular metabolism (9,
36, 41). The majority of LDL receptors expressed in mammals
are on the surfaces of liver cells, although a certain level of
LDL receptor expression also occurs in the peripheral tissue
(9). The LDL/LDL receptor lipid transport system appears to
be evolutionarily conserved, since apoB-100-like cholesterol
binding proteins (vitellogenins) have already been identified in
yolk of invertebrates, such as Caenorhabditis elegans and Dro-
sophila melanogaster (29, 34, 45). Furthermore, surface recep-
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tors of the LDL receptor family have been reported to be
expressed by invertebrates (34).
In addition to exogenous uptake of cholesterol, nearly all
mammalian cells are able to also synthesize cholesterol de
novo. In cells of peripheral tissues, excess cholesterol needs to
be removed and transported to the liver for reutilization and
excretion. The underlying mechanism of “reverse cholesterol
transport” is mediated by high-density lipoprotein (HDL) par-
ticles, the major component of which is apolipoprotein A-I
(apoA-I) (38). Lipid-free apoA-I is secreted predominantly by
the liver and intestine and acquires phospholipids and choles-
terol via cellular efflux from peripheral tissue cells and macro-
phages, giving rise to nascent HDL. Once mature, HDL particles
are transported to the liver, adrenal glands, and steroidogenic
tissue where they are recognized by the HDL receptor, scav-
enger receptor type B class I, upon which the process of “se-
lective lipid uptake” by the target cell is induced, which fun-
damentally differs from receptor-mediated endocytosis (9, 36,
38, 39). During “selective lipid uptake,” cholesterol and phos-
pholipids are effectively transferred to target cells, releasing
extracellular, lipid-depleted HDL particles which can reenter
circulation. Although LDL particles are the major carriers of
cholesterol in human blood, sera from rodents and ungulates
typically contain much higher levels of HDL components than
LDL components (10). Another difference concerns the extra-
cellular transfer of cholesteryl esters from HDL particles to
other lipoproteins (e.g., LDL) for further transport, which can
be observed only in humans and not in rodents (9). Although
as in the case of LDL receptors, the scavenger receptor type B
family appears to be evolutionarily conserved and occurs also
in invertebrates (15), soluble apolipoproteins, such as apoA-I
or apoE, are probably deuterostome specific and may have first
appeared around 450 million years ago in an Ordovician ver-
tebrate (27).
As yet, only two parasitic flatworm proteins which can
interact with the cholesterol and lipid transport machinery of
mammalian hosts have been reported and both derive from
trematodes, an LDL receptor-like very low-density lipoprotein
binding protein from Schistosoma japonicum (17) and a CD36-
like class B scavenger receptor from Schistosoma mansoni (15)
which interacts with modified host LDL at the tegumental
surface. As a first step toward the characterization of cestode
molecules that are involved in cholesterol uptake during infec-
tions of the intermediate host, we herein report the identifica-
tion and characterization of a secreted E. multilocularis pro-
tein, EmABP, which interacts with human apoA-I, the major
component of HDL particles for reverse cholesterol transport.
The role of EmABP in Echinococcus cholesterol uptake mech-
anisms is discussed in the background of what is known on the
function of the homologous apolipoprotein A-I binding pro-
tein (AI-BP) (26, 42, 44) in humans.
MATERIALS AND METHODS
Organisms and culture methods. All experiments were performed with the
natural Echinococcus multilocularis isolate H95 which was propagated in Mon-
golian jirds or Mongolian gerbils (Meriones unguiculatus) as described previously
(50). In vitro cultivation of metacestode vesicles under axenic conditions was
performed according to an established protocol (47), and protoscoleces were
isolated from in vivo-cultivated parasite material as described previously (5).
Pepsin activation of protoscoleces was performed as described previously (48) by
incubation of the larvae in pepsin and low pH (0.5 mg/ml pepsin in Hanks’
solution, pH 2.0, 37°C) for 3 h. Egg-free, adult E. multilocularis worms were
isolated from experimentally infected dogs essentially as previously described
(14) and kept on RNAlater RNA stabilization reagent (Qiagen) prior to RNA
isolation.
RT-PCR analyses. For RNA isolation from in vitro-cultivated metacestode
vesicles, protoscoleces, and adult worms, the RNeasy kit (Qiagen) was utilized
according to the manufacturer’s instructions. Three to five metacestode vesicles
of 5 mm in diameter or 30 to 50 protoscoleces were used per isolation step, and
the RNA was eluted in 30 l diethyl pyrocarbonate-treated water. For cDNA
synthesis, total RNA was reverse transcribed using the Omniscript RT kit
(Qiagen) according to a previously established protocol (5). Reverse transcrip-
tion-PCR (RT-PCR) for the Emabp and elp genes (3) was performed on cDNA
preparations from metacestode, invaginated protoscolex, and activated proto-
scolex using the primers LA1BP-5mod (5-GTG CAG GTC GCT CCG TGC
G-3) and LABPUP2 (5-GAG TGA GAT CAA GCA ATC TG-3) as well as
ELP-DW and ELP-UP (5), respectively. PCR products were separated on a 1%
agarose gel and stained with ethidium bromide.
Heterologous expression and purification of Emabp in Escherichia coli. For
heterologous expression in E. coli, the pBAD/TOPO-ThioFusion system (In-
vitrogen) was used. The Emabp reading frame was PCR amplified from E.
multilocularis cDNA using the primers APOBPDWY (5-CTC AGT CAG GAG
GAG GCG-3) and LA1BP-3 (5-CTT ATT GGG TGT CTG GAG G-3), and
the resulting fragment was cloned into pBAD/Thio via TA cloning, yielding
plasmid pPB-ExABP. In pPB-ExABP, Emabp was translationally fused to an
N-terminal thioredoxin moiety and carried the V5 antibody epitope (Invitrogen)
as well as a hexahistidine tag at the C terminus (thio-EmABP; 43 kDa). Recom-
binant protein expression was induced through the addition of arabinose to E.
coli cultures as previously described (46), and purification of thio-EmABP under
native conditions was performed according to established protocols (22, 48). For
a control, we recombinantly expressed a fusion protein that consisted of only the
thioredoxin moiety fused to the V5 epitope and the hexahistidine tags (thio-V5-
His6; 16 kDa) from plasmid pBAD/Thio (Invitrogen) and purified it under
identical conditions as thio-EmABP.
Antibodies and Western blot analyses. For the detection of EmABP in culture
supernatant and hydatid fluid, a rabbit anti-human AI-BP polyclonal antiserum
(42) was used. Detection of the heterologously expressed thio-EmABP and
thio-V5-His6 was done using the monoclonal (mouse) anti-V5 antibody (Invitro-
gen). For immunoprecipitation and detection of apoA-I, a goat anti-human
apoA-I antiserum (Acris Antibodies GmbH; catalogue no. R1029P) was used,
and Echinococcus antigen B was detected by employing the monoclonal antibody
EB7 (23). For Western blot detection, lysates or immunoprecipitation complexes
were separated on 12% acrylamide gels and transferred to nitrocellulose mem-
branes (Schleicher and Schuell GmbH). Detection was performed with the
above-mentioned antibodies using peroxidase-conjugated anti-mouse immuno-
globulin G or M (IgG/M), anti-rabbit IgG (both Jackson Immuno Research
Laboratories Inc.), or anti-goat/sheep IgG antibodies (Sigma) as secondary an-
tibodies according to the manufacturer’s instructions.
Immunoprecipitation of ApoA-I and EmABP from hydatid fluid and medium.
Thirty microliters of protein G-agarose (Upstate) was equilibrated in binding
buffer (1% bovine serum albumin and 1% Triton X-100 in phosphate-buffered
saline [PBS]). The anti-AI-BP (diluted 1:100) (41) or anti-apoA-I (1:100; Acris)
antibodies were bound to the agarose beads overnight at 4°C in binding buffer.
In vitro-cultivated metacestode vesicles (1 cm in diameter) were washed with
prewarmed PBS and transferred to an incubation tube. The vesicles were
pinched with a syringe, and the cellular fraction was pelleted by centrifugation
(1,000 rpm, 3 min) at 4°C. Hydatid fluid (supernatant) was transferred to a fresh
tube and kept on ice. After the protein G-antibody complexes were washed with
binding buffer, 2 ml of hydatid fluid was added and incubated under agitation
overnight at 4°C. The protein G-antibody complexes were pelleted by centrifu-
gation for 1 min at 14,000 rpm, and the supernatant was removed. The pellet was
subsequently washed three times with ice-cold washing buffer (1% Triton X-100
in PBS). Finally, 30 l of 2 sodium dodecyl sulfate sample buffer containing
-mercaptoethanol was added to the agarose beads, followed by boiling for 5 min
prior to acrylamide gel electrophoresis and Western blot detection as described
above.
Pulldown assays. To test the interaction between purified thio-EmABP and
apoA-I, agarose G beads (Upstate) (30 l) were equilibrated in binding buffer.
The anti-ApoA-I antibody (1:100) and human apoA-I (15 l) (1.32 mg/ml; Acris)
were bound to the beads overnight at 4°C in binding buffer. After the protein
G-antibody/antigen complexes had been washed in washing buffer, 30 l of
purified thio-EmABP (110 g/l) was added and incubated for 2 h at 4°C. The
antibody/antigen complexes were pelleted by centrifugation for 1 min at 14,000
rpm, and the pellet was washed three times with cold washing buffer prior to
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sample preparation for gel electrophoresis as described above. To precipitate
apoA-I from human serum, 50 l of protein A Sepharose (Sigma) was equili-
brated in binding buffer. The anti-AI-BP antibody (1:100) (42) and purified
EmABP (15 l) (110 g/l) were bound to the beads overnight at 4°C in binding
buffer. After the protein G-antibody/antigen complex was washed with washing
buffer, 1 ml of human serum was added. After overnight incubation at 4°C, the
antibody/antigen complexes were further processed essentially as described
above. Each assay was performed at least twice.
Computer-based analyses. Sequence alignments and comparisons were per-
formed using the Basic Local Alignment Search Tool (BLAST) software on the
SWISSPROT and nr-aa database collections available at http://blast.genome.jp,
the Schmidtea mediterranea genome database (http://smedgd.neuro.utah.edu/),
and the E. multilocularis genome project database (http://www.sanger.ac.uk
/Projects/Echinococcus/). Predictions of export-directing signal sequences,
transmembrane regions, and domains were done using the iPSORT algo-
rithm, available at http://hc.ims.u-tokyo.ac.jp/iPSORT/ (2) and the Simple
Modular Architecture ResearchTools (SMART), available at http://smart
.embl-heidelberg.de/ (30). Secondary structure predictions were made using
the Jpred 3 algorithm (http://www.compbio.dundee.ac.uk/www-jpred/index
.html) as described previously (13).
Nucleotide sequence accession number. The complete Emabp cDNA se-
quence reported in this paper was deposited in the GenBank database under the
accession number FM958505.
RESULTS
Characterization of the Emabp cDNA and genomic locus.
During previous studies of the trans-splicing mechanism in
Echinococcus multilocularis, we have established cDNA librar-
ies for trans-spliced mRNAs, isolated from in vitro-cultivated
metacestode vesicles and protoscoleces (4). Approximately 300
cDNAs from each library were sequenced and subjected to
BLAST sequence analyses using the SWISSPROT and nr-aa
databases. One of the characterized clones, designated Z2-45,
which was derived from the metacestode cDNA library, en-
coded a protein with significant homology to human AI-BP
(42) and was further analyzed. Due to this homology and to the
apoA-I binding activity of the encoded protein (see below),
this gene was named Emabp (for Echinococcus multilocularis
apoA-I binding protein), encoding the protein EmABP. The
full-length Emabp cDNA comprised 950 nucleotides [exclud-
ing the spliced leader (SL) and the poly(A) tail] and contained
a putative polyadenylation signal (AATAAA), 17 nucleotides
upstream of the poly(A) tail. Immediately following the SL,
there was an open reading frame which coded for a 273-amino-
acid protein (theoretical molecular mass of 30 kDa) which
displayed significant homologies (up to 60% identical and 72%
similar residues) to various mammalian AI-BP orthologs (Fig.
1) and somewhat lower homologies to YjeF_N domain-con-
taining proteins of invertebrates and bacteria (data not shown).
Using SMART analyses, a YjeF_N domain was identified in
EmABP between residues Y47 and C220, and all residues that
are known to be invariant or highly conserved in YjeF_N
domains were also present in EmABP (Fig. 1). Furthermore,
using the computer-based program iPSORT, an export-direct-
ing signal sequence of 30 amino acids was identified at the N
terminus of EmABP (Fig. 1), leading to a mature protein of
26.6 kDa after cleavage. Secondary structure predictions were
performed using the Jpred 3 algorithm (13) for EmABP and
human AI-BP and were compared with crystallographic data
previously obtained for murine AI-BP (26). In all three cases,
a very similar distribution of -helices and -strands was ob-
served, indicating that all three proteins are capable of adopt-
ing a Rossmann-like fold in the YjeF_N domain (data not
shown). Homology searches in expressed sequence tag data-
bases of the related parasitic tapeworm Schistosoma japonicum
(31) and the free-living planarian Schmidtea mediterranea (43)
revealed the presence of EmABP orthologs in both organisms,
which displayed similarity values to the Echinococcus protein
FIG. 1. Structural features and sequence homologies of EmABP. Displayed is a CLUSTAL V alignment (MEGALIGN) between E. mul-
tilocularis EmABP (this work), human AI-BP (Homo sapiens AI-BP [HsAI-BP]) (GenBank accession no. AJ315849) (42) as well as EmABP
orthologs from S. japonicum (SjABP) (GenBank accession no. AY815871) (31) and S. mediterranea (SmedABP) (mk4.005551.03; http://smedgd
.neuro.utah.edu/) (43). Amino acid positions are numbered at the right margin. Residues that are conserved in at least two of the sequences are
printed in white on black background. Homologies of the aligned proteins to EmABP are indicated at the end of the alignment (percent similarity
and percent identity). A thick dashed overline indicates the YjeF_N domain, as predicted by the SMART algorithm (30). Arrows above and below
the alignment indicate predicted signal peptidase cleavage sites in EmABP and human AI-BP (42), respectively. Asterisks above and below the
alignment mark the positions of introns in the coding regions for EmABP and human AI-BP (44), respectively. Open circles below the
alignment indicate invariant residues, and closed circles indicate highly conserved residues within YjeF_N domains (26). A circled “P” below
the alignment indicates the serine residue which, in murine AI-BP, is phosphorylated by protein kinase A (26). Gaps introduced to maximize
alignment are indicated by dashes in the sequences.
5566 BERNTHALER ET AL. INFECT. IMMUN.
 at Universitaet Zuerich on Novem
ber 18, 2009 
iai.asm
.org
D
ow
nloaded from
 
in the range of values observed between EmABP and human
AI-BP. Interestingly, neither in the trematode nor in the pla-
narian ortholog was a signal sequence present (Fig. 1). Be-
tween the N-terminal signal sequence and the YjeF_N domain,
mammalian AI-BP orthologs typically carry a stretch of 25
amino acids (Fig. 1) which contains a serine residue that,
during murine sperm capacitation, is phosphorylated by pro-
tein kinase A (26). A similar sequence stretch was absent in
EmABP and was also missing upstream of the YjeF_N domain
in the Schistosoma and Schmidtea orthologs (Fig. 1).
Fernandez et al. (18) have previously generated SL- and
oligonucleotide-capped cDNA libraries from E. granulosus
which are available under ftp://ftp.sanger.ac.uk/pub/pathogens/
Echinococcus/. Homology searches in these databases revealed
the presence of two full-length clones coding for proteins with
98% (EGPSPsl-14g07.q1k) and 97% (EGPSPsl-10b12.q1k)
identity to EmABP. Both derived from a SL library made from
protoscolex mRNA and contained the E. granulosus SL at the
5 end. Compared to EmABP, four amino acid exchanges were
observed in the sequence from EGPSPsl-14g07.q1k (Q2L, P5L,
N182K, and K198E) and two additional exchanges in the EGPSPsl-
10b12.q1k sequence (K38R and Y47H).
The E. multilocularis genome is currently being se-
quenced, and sequence information representing fourfold
coverage is available under http://www.sanger.ac.uk/Projects
/Echinococcus/. When the cDNA sequence of Emabp was
compared with the available data, all exons were identified
on three adjacent contigs and the reading frame was shown
to be interrupted by six introns (Fig. 1) which all contained
canonical GT and AG residues at the 5 and 3 ends, respec-
tively. The human gene encoding AI-BP contains five introns
(44) which all map to identical positions as the first five introns
of Emabp (Fig. 1), indicating that both genes share a common
genetic ancestor. On the genome sequence available at this
time, no further gene encoding a YjeF_N domain protein was
identified. Hence, Emabp is most probably a single-copy gene.
Expression of Emabp in Echinococcus larval stages and
adult worms. The expression of Emabp in larval stages was
analyzed by semiquantitative RT-PCR. As shown in Fig. 2,
Emabp transcripts were detected in metacestode vesicles, in
resting protoscoleces, and to a somewhat lower extent, in the
protoscolex after activation through pepsin/low-pH treatment.
We also isolated RNA from adult E. multilocularis worms (free
of eggs) and clearly identified Emabp in respective cDNA
preparations by RT-PCR (data not shown). Taken together,
these data indicated that Emabp is constitutively expressed
throughout the parasite’s life cycle.
Recombinant expression and purification of EmABP. The
Emabp reading frame, excluding the codons for the signal
sequence, was translationally fused to thiredoxin (N-terminal)
as well as a hexahistidine tag and the V5 antibody epitope
(both C-terminal) using the pBAD/Thio-TOPO system (In-
vitrogen). The induced fusion protein (thio-EmABP) was sub-
sequently purified under native conditions (Fig. 3A). An anti-
body against human AI-BP has previously been produced by
immunization of a rabbit with the peptide V263PPALEKKYQ
LNLPPYPDTE282 (42). Since EmABP contained a very simi-
lar sequence (V236PPLLADKYNLCLPPYPGAS255 [identical
residues underlined]), we tested whether the anti-AI-BP anti-
body also detected EmABP, which was indeed the case (Fig.
3B). On the other hand, the anti-AI-BP antibody did not in-
teract with the thio-V5-His6 control protein (data not shown).
Secretion of EmABP and detection of apoA-I in hydatid
fluid. Since an export-directing signal sequence was identified
in the deduced amino acid sequence of EmABP, we investi-
gated whether the protein is secreted into the extraparasitic
environment by the E. multilocularis metacestode. In vitro-
cultivated metacestode vesicles (47, 50) were taken out of
culture, thoroughly washed, and placed into minimal essential
medium without protein supplements for 12 and 24 h. Western
blot analyses of the supernatant with the anti-AI-BP antibody
did not reveal bands, which was most probably due to a low
concentration of secreted factors. We therefore employed the
anti-AI-BP antibody in immunoprecipitation experiments and
FIG. 2. Emabp expression patterns. Total RNA has been isolated
from in vitro-cultivated metacestode vesicles (MC) as well as from
dormant (Pd) and low-pH/pepsin-activated (Pa) protoscoleces and was
reverse transcribed into cDNA. RT-PCR was performed using primers
specific for Emabp (abp) and the constitutively expressed control gene
elp (3, 5). PCR products were separated on a 1% agarose gel and
stained with ethidium bromide.
FIG. 3. Heterologous expression, purification, and detection of
EmABP. (A) Heterologous expression in E. coli and purification. The
Emabp reading frame was cloned in the pBAD/TOPO ThioFusion
expression system (Invitrogen) in E. coli. Lysates of arabinose-induced
(lane 2) and noninduced (lane 1) E. coli were separated on an 12%
acrylamide gel, transferred to a nitrocellulose membrane, and analyzed
using the anti-V5 antibody (Invitrogen). Heterologously expressed
thio-EmABP was purified under native conditions, and samples of
elution steps 1 to 5 were applied to lanes 3 to 7, respectively. Separa-
tion of the samples and protein detection was performed as described
above. The positions of molecular size markers (in kilodaltons) are
indicated to the left of the gel. (B) Detection of thio-EmABP using an
anti-AI-BP antibody. Lysates of recombinant E. coli carrying plasmids
for the thio-EmABP fusion protein were prepared after arabinose
induction (lane 1) or without arabinose induction (lane 2), separated
on an 12% acrylamide gel, transferred to a nitrocellulose membrane,
and detected by using an anti-AI-BP (human) antibody (42).
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could successfully precipitate a single protein of the expected
size (Fig. 4), indicating that EmABP is secreted by the E.
multilocularis metacestode. For a control, we performed im-
munoprecipitation with an antibody against antigen B, one of
the most abundant proteins in hydatid fluid (33). However, we
never obtained bands despite the fact that antigen B was easily
detected in hydatid fluid using the same antibody. These re-
sults showed that the metacestode vesicles in our assays were
structurally intact and that the supernatant did not contain
hydatid fluid contaminants.
Next, we investigated whether EmABP is also present in
hydatid fluid. In Western blot analyses using the anti-AI-BP
antibody on freshly isolated hydatid fluid, only a very faint
band at the expected size was obtained (data not shown).
Immunoprecipitation was therefore performed as described
above with hydatid fluid from in vitro-cultured metacestode
vesicles instead of supernatant, and as shown in Fig. 4, a pro-
tein of the expected size was clearly present. Since we never
detected mammalian AI-BP in the conditioned medium that
was used to cultivate metacestode vesicles in vitro (data not
shown), we concluded that the immunoreactive protein in hy-
datid fluid was indeed EmABP and not host-derived AI-BP
that had been transported across the parasite’s laminated and
germinal layers. Using a commercial antibody against apoA-I,
we also tried to immunoprecipitate the mammalian apoli-
poprotein from hydatid fluid and were successful (Fig. 4).
Since apoA-I orthologs are usually found only in higher meta-
zoans (27) and since we could not find indications that the
parasite’s genome contains a gene for such an ortholog, we
concluded that this immunoreactive protein indeed derived
from the host and not from E. multilocularis. Taken together,
these data indicated that EmABP is secreted by the metaces-
tode both into the interior lumen (hydatid fluid) and into the
exterior. Furthermore, similar to other host serum factors like
albumin or immunoglobulins (11), apoA-I is present in hydatid
fluid.
Interaction of EmABP with human apoA-I. Human AI-BP
has originally been identified in a screen for proteins that
interact with apoA-I (42). To investigate similar activities for
EmABP, immunoprecipitation and pulldown experiments
were carried out. First, we tested whether the purified thio-
EmABP fusion protein was able to interact with purified hu-
man apoA-I in a pulldown assay. As shown in Fig. 5A, thio-
EmABP clearly interacted with apoA-I. On the other hand, we
never observed interaction between the control protein thio-
V5-His6 and apoA-I (data not shown). Second, we tested
whether purified thio-EmABP was able to precipitate apoA-I
from human serum and used sera from healthy donors and
patients with active AE. In both cases, thio-EmABP precipi-
tated a protein of the expected size which was immunoreactive
with the anti-apoA-I antibody, while no precipitation was ob-
served for the control protein thio-V5-His6. Taken together,
the above experiments clearly indicated that EmABP, like its
human ortholog AI-BP, is able to interact with human apoA-I.
EmABP is not antigenic. Since EmABP is apparently se-
creted by the E. multilocularis metacestode into the surround-
ing (host) medium, we finally investigated whether patients
suffering from AE and CE produce antibodies against the
parasite protein. In established enzyme-linked immunosorbent
assays which utilize the parasite-derived protein Elp (also
called EM10) for serological detection of AE and CE (24, 40),
we consistently measured significantly higher levels of IgG and
FIG. 4. Detection of EmABP in hydatid fluid and culture superna-
tant. (Left, top) Metacestode vesicles from in vitro culture were thor-
oughly washed and kept for 12 h (lane 1) or 24 h (lane 2) in serum-free
culture medium. Immunoprecipitation was subsequently carried out
using the anti-AI-BP antibody (42). The precipitates were separated
on a 12% acrylamide gel and analyzed using the anti-AI-BP antibody
(ABP). (Bottom) To assess vesicle integrity, vesicle supernatant after
12 h (lane 1) and 24 h (lane 2) of incubation was subjected to immu-
noprecipitation using the monoclonal EB7 antibody, directed against
Echinococcus antigen B (AgB) (23). Size separation and Western blot
detection were performed as described above for EmABP, using the
EB7 antibody instead of the anti-AI-BP antibody. For a control, hy-
datid fluid from in vitro-cultivated vesicles was size separated, and
Western blot detection was performed using the EB7 antibody (lane
3). (Right) Hydatid fluid was isolated from in vitro-cultivated meta-
cestode vesicles and subjected to immunoprecipitation using the anti-
AI-BP antibody (top) or a commercial anti-apoA-I antibody (bottom).
The precipitates were separated on a 12% acrylamide gel and trans-
ferred to a nitrocellulose membrane, and detection was carried out
using the antibodies that had been used for immunoprecipitation. The
sizes of the precipitated proteins (in kilodaltons) are indicated to the
left of the gels.
FIG. 5. Interaction between EmABP and human apoA-I. (A) In-
teraction of purified EmABP and apoA-I. Purified, recombinant
apoA-I was bound to protein G-agarose beads using the anti-apoA-I
antibody. The recombinantly expressed, purified thio-EmABP fusion
protein was added, and after 2 h of incubation, agarose G beads were
pelleted and thoroughly washed. The protein complexes were then
separated on a 12% acrylamide gel, and Western blot detection using
the anti-V5 antibody (Invitrogen) was carried out. In lane 1, the anti-
apoA-I antibody, apoA-I, and thio-EmABP were applied. Conditions
in lane 2 were identical to lane 1 except that apoA-I was omitted. In
lane 3, the original input of thio-EmABP is shown. (B) Precipitation of
apoA-I from human serum. The anti-V5 antibody was bound to Sepha-
rose A beads (lanes 1 to 3), followed by the addition of the thio-
EmABP fusion protein (lane 3) or the thio-V5-His6 control protein
(lane 2) (in lane 1, no fusion protein was added). The antibody protein
complexes were incubated overnight with serum from AE patients ()
or healthy donors (). The Sepharose A beads were then pelleted and
thoroughly washed. Protein complexes were separated on an 12%
acrylamide gel, transferred to a nitrocellulose membrane, and detected
using an anti-apoA-I antibody.
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IgE antibodies against Elp in sera from patients with con-
firmed AE and CE compared to sera from healthy donors.
When using thio-EmABP as an antigen, on the other hand, no
elevated antibody levels were detected in patient sera. Further-
more, anti-EmABP antibody levels in AE patients were con-
sistently as low as anti-Elp antibody levels in healthy donors
(data not shown). Taken together, we conclude from these
experiments that EmABP is not acting as a parasite antigen
during active infections, which is most likely a result of its
overall high homology to human AI-BP.
DISCUSSION
In the present study, we have identified a novel protein,
EmABP, which is secreted by the Echinococcus multilocularis
metacestode into the surrounding host medium (as well as into
hydatid fluid; for a diagrammatic representation of the E. mul-
tilocularis metacestode, please see reference 8) and interacts
with host-derived apoA-I. Due to the crucial function of
apoA-I in mammalian lipid and cholesterol transport processes
mediated through HDL particles, this feature suggests a po-
tential role of EmABP in interfering with host lipid and cho-
lesterol transport.
The fact that E. multilocularis and E. granulosus, like other
parasitic flatworms, cannot de novo synthesize cholesterol and
the majority of other lipid components, has already been firmly
established by previous studies (19, 20, 35). This is supported
by our own analyses of the first draft version of the E. mul-
tilocularis genome, which showed that genes for the majority of
enzymes that are involved in cholesterol synthesis in other
organisms (51) are absent in the cestode (data not shown). In
the case of the E. granulosus metacestode, an uptake of radio-
actively labeled, host-derived cholesterol during an infection of
laboratory animals has already been demonstrated (20), and it
is reasonable to assume that E. multilocularis employs choles-
terol uptake mechanisms similar to those of the closely related
dog tapeworm. Hence, in addition, or as an alternative, to
interfering with lipid/cholesterol transport of the host, EmABP
might be actively involved in cholesterol and lipid uptake by
the parasite.
Like its mammalian ortholog AI-BP, EmABP belongs to the
widespread YjeF_N protein family, members of which are
present in eukaryotes, bacteria, and archaea (1). Unfortu-
nately, neither the general biochemical properties nor the cel-
lular functions of YjeF_N proteins are known at this time, the
protein family being in the top 10 list of highly attractive
targets for functional characterization (21). YjeF_N domains
either occur as single proteins, like in the case of EmABP and
AI-BP, or as fusions with other domains and are commonly
associated with enzymes (1). Structurally, the YjeF_N domain
displays a Rossman-like fold, a structural motif found in pro-
teins that bind nucleotides, especially the cofactor NAD (32),
and it is generally thought that the domain exerts an unknown
enzymatic activity, such as dephosphorylation, demethylation,
and phosphoester or glycosyl bond hydrolysis (1). Although the
precise biochemical and cell biological functions of AI-BP are
unknown at this time, several lines of evidence indicate that
this protein plays a role in cellular cholesterol and lipid trans-
port mechanisms in a variety of organs in higher eukaryotes.
First, AI-BP is expressed in a wide variety of mammalian
tissues, and apart from its binding capacity to apoA-I, it local-
izes in domains in sperm in which cholesterol is known to be
concentrated (26). Second, AI-BP is released into the medium
during sperm capacitation, a process that is accompanied by
cholesterol release (26). Third, immunohistochemical analyses
of human testes and ovaries identified AI-BP in various cell
types coexpressed with ABCA1 (ATP binding cassette trans-
porter A1), the main determinant for plasma HDL, which is
involved in cellular lipid transport and steroid hormone syn-
thesis and which also interacts with apoA-I (44). Apart from its
function in spermiogenesis and oogenesis, AI-BP seems to also
play an important role in hepatocyte metabolism, since it is
highly expressed in liver tissue as well as in HepG2 cells (42).
Interestingly, although sera from healthy donors do not con-
tain AI-BP, increased plasma levels were observed in patients
suffering from systemic inflammation and sepsis, which could
be linked to general changes in plasma lipoprotein metabolism
that occur during inflammatory processes (35, 42). Hence,
once released by the E. multilocularis metacestode at the pri-
mary site of infection (the liver), EmABP could indeed affect
both the physiology of hepatocytes and the local immune re-
sponse. It has to be kept in mind, however, that apoA-I and
other lipid transporters are among the most abundant compo-
nents of human serum (38) and that probably very large
amounts of EmABP would have to be secreted in order to
significantly interfere with this equilibrium. Hence, as further
outlined below, we clearly favor a role for EmABP in choles-
terol uptake mechanisms of the parasitic metacestode over a
function in altering the host’s immune response.
Apart from Emabp expression in the metacestode, we also
found the gene transcribed in adult worms. Due to the absence
of apoA-I and apoA-I-dependent cholesterol transport activi-
ties in the gut of the definitive host, we do not consider it likely
that the suggested role of the protein in cholesterol uptake is
shared between metacestode vesicles and adult worms. Since
AI-BP orthologs are apparently also expressed by adult schis-
tosomes and (free-living) planarians, they most probably exert
additional cellular functions that still have to be determined.
Due to the location of human AI-BP in the testes and ovaries
(42), flatworm EmABP orthologs might be specifically involved
in spermatogenesis and oogenesis, which does, however,
clearly require additional experimentation.
One striking difference between mammalian AI-BP or-
thologs and YjeF_N family members from bacteria, lower eu-
karyotes, or invertebrates is the presence of an export-directing
signal sequence at the N termini of the mammalian proteins
(42, 44). Interestingly, Rudolph et al. (44) identified two addi-
tional YjeF_N proteins in humans which lack a signal se-
quence, are not secreted, and fail to interact with apoA-I. On
the basis of immunolocalization studies of testes and ovaries,
these authors concluded that AI-BP and both additional mam-
malian YjeF_N proteins are involved in mechanisms of cho-
lesterol processing and steroid hormone metabolism and that
the specific function of AI-BP is to link these functions to the
HDL pathway (44). Since apoA-I and HDL transport mecha-
nisms have arisen relatively late in animal evolution (27), it is
reasonable to assume that this was accompanied by the acqui-
sition of a signal sequence and thus, secretion of AI-BP into
the extracellular environment. In this context, it is interesting
to note that EmABP contains a signal sequence which is absent
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in the AI-BP orthologs of the related flatworms S. japonicum
(parasitic) and S. mediterranea (free-living) and which has ap-
parently been acquired during cestode evolution through
genomic rearrangements (as indicated by the presence of an
intron at the respective position). The fact that this signal
sequence is indeed active is clearly indicated by our immuno-
precipitation experiments which detected EmABP in the ex-
tralarval medium and in hydatid fluid. Hence, like in the case
of mammalian AI-BPs, EmABP might have acquired a signal
sequence to specifically link the host’s HDL transport mecha-
nisms to cholesterol and lipid uptake and metabolism by the
parasite.
It is well established that host serum components, such as
albumin or immunoglobulins, are present in hydatid fluid (11),
and in this study, we have identified apoA-I as another host
serum factor which is apparently transported from the sur-
rounding host medium into the metacestode lumen. Unfortu-
nately, the underlying transport mechanisms for any serum
component are completely unknown at present. Likewise, little
is known on protein secretion mechanisms in Echinococcus.
Therefore, at this time, we cannot tell whether EmABP is
simultaneously secreted by the metacestode into the hydatid
lumen and into the exterior medium or whether the protein is
first secreted into the surrounding medium and subsequently
transported across the germinal layer into hydatid fluid. The
fact that we measured somewhat smaller amounts of secreted
EmABP in two different samples of in vitro-cultured metaces-
tode vesicles after 24 h compared to 12 h might indeed indicate
that the protein is first secreted and then transported into the
parasite lumen once a critical external concentration is built
up. This is supported by results from our Western blot analyses
showing that EmABP is not one of the major constituents of
hydatid fluid but rather is present in smaller amounts. How-
ever, although we have used comparable numbers of metaces-
tode vesicles in both experimental settings, these might have
had slight physiological differences, so this hypothesis surely
awaits further experimentation. To this end, we are currently
trying to use recombinantly expressed, purified EmABP to-
gether with apoA-I and in vitro-reconstituted HDL particles
(37) to study whether the parasite protein might be directly
involved in the transport host components into in vitro-culti-
vated metacestode vesicles. In any case, the fact that both
apoA-I and EmABP are present in hydatid fluid indicates that
the parasite protein plays a role in parasite-specific physiolog-
ical processes. On the basis of the above outlined functional
properties of the human ortholog AI-BP, we suggest that this
function involves cholesterol metabolism and uptake by E.
multilocularis metacestode vesicles.
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